Neurovirology: Viruses and the Brain: Viruses and the Brain

In stock
Regular price 68.500 KD inc. VAT
License
Table of contents
  • Contentsv
  • Part 1: Basic Models1
  • Chapter 1. Genetic Determinants of Neurovirulence of Murine Oncornaviruses3
  • I. Introduction3
  • II. Clinicopathological Manifestations of Neurovirulent Murine Oncornavirus Infection6
  • III. Mapping of Viral Determinants of Neurologic Disease8
  • IV. Viral Sequences that Determine Neuroinvasiveness12
  • V. Host Factors and Neuroinvasiveness15
  • VI. Viral Envelope Sequences that Determine Neurotoxicity17
  • VII. Cell Types Involved in Neurovirulence21
  • VIII. Envelope Expression in Microglia23
  • IX. Role of Inflammation25
  • X. Retroviruses and Multiple Sclerosis27
  • XI. Concluding Remarks29
  • References29
  • Chapter 2. Pseudorabies Virus Neuroinvasiveness: A Window into the Functional Organization of the Br39
  • I. Viruses and the Nervous System39
  • II. Neuronal Architecture and Neurotropic Viruses41
  • III. Importance of Using Well-Characterized Strains of Virus44
  • IV. Replication and Intracellular Spread of Pseudorabies Virus in the Brain46
  • V. Brain Defenses and Neuroinvasiveness57
  • VI. Recombinant Viruses and the Nervous System62
  • VII. Viral Circuit Analysis: Future Applications65
  • VIII. Conclusions66
  • References66
  • Chapter 3. Neurovirology and Developmental Neurobiology73
  • I. Introduction73
  • II. Central Nervous System Development74
  • III. Virus Replication79
  • IV. Alphavirus Infections as Examples of Age-Related Neurovirulence82
  • V. Virus Infections of Developing Nervous System97
  • VI. Other Important Infections of the Developing Human Central Nervous System105
  • References109
  • Part 2: Viral Immune Responses in the Central Nervous System125
  • Chapter 4. Chemokines and Viral Diseases of the Central Nervous System127
  • I. Introduction127
  • II. Chemokines and their Receptors: An Overview129
  • III. Chemokines and their Receptors in the Central Nervous System139
  • IV. Chemokines and their Receptors in Viral Diseases of the Central Nervous System143
  • V. Concluding Remarks157
  • References159
  • Chapter 5. Regulation of T Cell Responses During Central Nervous System Viral Infection175
  • I. Introduction175
  • II. Effector Functions of T Cells during CNS Viral Infection176
  • III. Regulation of T Cell Responses during CNS Viral Infection179
  • IV. Concluding Remarks192
  • References194
  • Chapter 6. Virus-Induced Autoimmunity: Epitope Spreading to Myelin Autoepitopes in Theiler’s Virus199
  • I. Introduction199
  • II. Relevance of Murine TMEV-Induced Demyelinating Disease to Human Multiple Sclerosis201
  • III. TMEV Infection as Model of Persistent Virus-Induced, CD4+ T Cell-Mediated Demyelination201
  • IV. Virus-Specific CD4+ T Cell Respones Initiate Disease204
  • V. Myelin-Specific CD4+ T Cell Responses: Pathologic Role in Chronic Theiler’s Virus-Induced Demye204
  • VI. Myelin Epitope-Specific CD4+ T Cell Responses in TMEV-Infected Mice Arising via Epitope Spreadin208
  • VII. Endogenous Presentation of Virus and Myelin Epitopes by CNS-Resident Antigen-Presenting C in TM209
  • VIII. Summary211
  • References212
  • Chapter 7. Selection of and Evasion from Cytotoxic T Cell Responses in the Central Nervous System219
  • I. Objectives of this Review219
  • II. Introduction220
  • III. Selection of CTL Escape Mutants in Viral Encephalomyelitis226
  • IV. Conclusions and Future Directions234
  • References236
  • Chapter 8. DNA Immunization and Central Nervous System Viral Infection243
  • I. Virus Infections of the Central Nervous System244
  • II. Antiviral Immune Response249
  • III. Central Nervous System as a Haven for Viruses256
  • IV. Vaccinating Against Virus-Induced CNS Diseases: An Introduction to Mouse Models258
  • V. DNA Vaccines and CNS Viral Infections262
  • References266
  • Part 3: Spongiform Encephalopathies275
  • Chapter 9. Transmissible Spongiform Encephalopathies and Prion Proten Interconversions277
  • I. Introduction277
  • II. Tranmissible Spongiform Encephalopathies in Humans and Animals279
  • III. Prion Protein: Cellular and Molecular Aspects285
  • IV. Current Issues in TSE Research295
  • References302
  • Chapter 10. Spongiform Encephalopathies: Insights from Transgenic Models313
  • I. Introduction313
  • II. Transgenic Models for Human Hereditary Prion Diseases317
  • III. Mice as Transgenic Models319
  • IV. Structure-Function Studies on PrP Gene322
  • V. Species Barrier.325
  • VI. Prion Strains328
  • VII. Ectopic Expression of PrP in PrnP-Ablated Mice330
  • VIII. Prions and the Central Nervous System332
  • IX. Conclusion342
  • References343
  • Part 4: HIV: Human Immunodeficiency Virus353
  • Chapter 11. The Blood–Brain Barrier and AIDS355
  • I. Introduction355
  • II. AIDS Dementia versus HIV Encephalitis357
  • III. Timing of Viral Entry into the CNS360
  • IV. Mechanisms and Models of Viral Entry360
  • V. The Central Nervous System as a Viral Reservoir368
  • VI. Animal Models371
  • References380
  • Chapter 12. Neuroimmune and Neurovirological Aspects of Human Immunodeficiency Virus Infection389
  • I. Introduction389
  • II. Clinical Aspects392
  • III. Virological Aspects399
  • IV. Neuropathogenesis400
  • V. Animal Models415
  • VI. Unanswered Questions417
  • VII. Summary418
  • References418
  • Chapter 13. Simian Immunodeficiency Virus Model of HIV-Induced Central Nervous System Dysfunction435
  • I. Introduction435
  • II. Animal Models437
  • III. Brain Infection445
  • IV. Host Responses446
  • V. Chemokines and Their Receptors452
  • VI. Central Nervous System Dysfunction454
  • VII. Chemotherapy and Prophylaxis457
  • VIII. Conclusion458
  • References459
  • Chapter 14. Neuroendocrine-Immune Interactions during Viral Infections469
  • I. Introduction469
  • II. Hypothalamic–Pituitary–Adrenal (HPA) Axis470
  • III. Glucocorticoid Induction during Viral Infections: Mechanisms and Signaling Pathways474
  • IV. Impact of Glucocorticoids on Target Tissues491
  • V. Role of HPA in Shaping Immune Response during Viral Infection494
  • VI. Conclusions500
  • References500
  • Part 5: Preclinical and Clincal Models515
  • Chapter 15. Role of Viruses in Etiology and Pathogenesis of Multiple Sclerosis517
  • I. Introduction517
  • II. Etiology of Multiple Sclerosis518
  • III. Viruses in Multiple Sclerosis529
  • IV. Conclusions543
  • References544
  • Chapter 16. Bornavirus Tropism and Targeted Pathogenesis: Virus–Host Interactions in a Neurodevelo557
  • I. Introduction557
  • II. Mechanisms for Neurotropism: Phosphorylation of Borna Disease Virus Phosphoprotein by Protien Ki558
  • III. Mechansisms for BDV Persistence559
  • IV. Borna Disease Rat Models for Human Central Nervous System Disorders561
  • V. Summary576
  • References576
  • Chapter 17. Paradigms for Behavioral Assessment of Viral Pathogenesis583
  • I. Introduction583
  • II. Behavioral Effects of Viral Infection in Rodents585
  • III. Behavioral Effects of Viral Infection in Nonhuman Primates599
  • IV. Conclusion617
  • References618
  • Index627
Book details
  • Vendor Elsevier S & T
  • SKU 9780120398560
  • ISBN-13 9780080493800

Do you have questions about this book?

Ask an expert!

This volume is the first in a planned series of thematic volumes for Advances in Virus Research. It covers the etiology, pathogenetic mechanisms, and clincial consequences of human neurotropic viruses. Buchmeier is a virologist, Campbell an immunologist, and both are extremely well known in their fields.

Numerous illustrations including colour
Knowledgeable discussion of the potential role of viral infections in teratogenic and developmental disorders.
Frank discussion of the role of stress in disease
Behavioural consequences of chronic CNS infection